April 7, 2021

LumiraDx, a Next-Generation Point of Care Diagnostics Testing Company to List on Nasdaq via Merger with CA Healthcare Acquisition Corp

BOSTON & LONDON–(BUSINESS WIRE)–LumiraDx, a Next-Generation Point of Care Diagnostics Testing Company to List on Nasdaq via Merger with CA Healthcare Acquisition Corp


Leave Comment


Your Name *
Your Email *
Your Website
Comment *